These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6163417)

  • 41. Neutropenia and thrombocytopenia after repeated courses of leucocyte interferon.
    Urbaniak SJ; Halliday IM; Beveridge GW; Kay AV
    Lancet; 1978 Mar; 1(8063):553-4. PubMed ID: 76091
    [No Abstract]   [Full Text] [Related]  

  • 42. Prediction models for feverishness developed during interferon therapy of chronic hepatitis C patients.
    Uesawa Y; Motege E; Dai Y; Ishii K; Mohri K
    Pharmazie; 2010 Feb; 65(2):114-6. PubMed ID: 20225655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Interferon in antitumoral chemotherapy].
    Soria M
    Recenti Prog Med; 1981 May; 70(5):494-523. PubMed ID: 6171850
    [No Abstract]   [Full Text] [Related]  

  • 44. Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.
    Gutterman JU; Fine S; Quesada J; Horning SJ; Levine JF; Alexanian R; Bernhardt L; Kramer M; Spiegel H; Colburn W; Trown P; Merigan T; Dziewanowski Z
    Ann Intern Med; 1982 May; 96(5):549-56. PubMed ID: 6176159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative antiviral efficiency of leukocyte and bacterially produced human alpha-interferon in rhesus monkeys.
    Schellekens H; de Reus A; Bolhuis R; Fountoulakis M; Schein C; Ecsödi J; Nagata S; Weissmann C
    Nature; 1981 Aug; 292(5825):775-6. PubMed ID: 6167863
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of interferon therapy on heart rate and sympathetic nervous system.
    Yamamoto T; Tsuchihashi T; Hayashi J; Kashiwagi S
    Fukuoka Igaku Zasshi; 1998 Jul; 89(7):207-15. PubMed ID: 9745188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toxicity of interferon.
    Fumarola D
    Br Med J (Clin Res Ed); 1981 Nov; 283(6304):1468-9. PubMed ID: 6172179
    [No Abstract]   [Full Text] [Related]  

  • 48. [Antiviral and anticellular activity of human leukocytic and fibroblastic interferons in homo- and heterologous cells].
    Orlova TG; Zhdanov LV; Timofeev IV; Indikova IN; Mentkevich LM
    Vopr Virusol; 1981; (4):404-7. PubMed ID: 6171095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient tolerance to interferon: clinical and laboratory assessments.
    Fischl MA
    Med Clin North Am; 1986 May; Suppl():41-5. PubMed ID: 2426535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapy with interferon.
    MacLeod AJ
    N Engl J Med; 1979 Jul; 301(2):106. PubMed ID: 449933
    [No Abstract]   [Full Text] [Related]  

  • 51. Tolerability of pure fibroblast interferon in man.
    Billiau A; Heine JW; Van Damme J; Heremans H; De Somer P
    Ann N Y Acad Sci; 1980; 350():374-5. PubMed ID: 6165288
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison of the suppression of cell and virus growth in transformed human cells of leukocyte and fibroblast interferon.
    Kuwata T; Fuse A; Suzuki N; Morinaga N
    J Gen Virol; 1979 May; 43(2):435-9. PubMed ID: 225426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assay of growth inhibition in lymphoblastoid cell cultures.
    Evinger M; Pestka S
    Methods Enzymol; 1981; 79(Pt B):362-8. PubMed ID: 6173685
    [No Abstract]   [Full Text] [Related]  

  • 54. The pharmacology and toxicology of the interferons: an overview.
    Mannering GJ; Deloria LB
    Annu Rev Pharmacol Toxicol; 1986; 26():455-515. PubMed ID: 2424363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and immunologic effects of recombinant leukocyte A interferon in eight patients with advanced cancer.
    Horning SJ; Levine JF; Miller RA; Rosenberg SA; Merigan TC
    JAMA; 1982 Mar; 247(12):1718-22. PubMed ID: 6174742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assay of the inhibitory activities of human interferons on the proliferation and locomotion of fibroblasts.
    Tamm I; Pfeffer LM; Murphy JS
    Methods Enzymol; 1981; 79(Pt B):404-13. PubMed ID: 6173687
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacological aspects of clinical stage I/II trials with human beta interferon in children.
    Treuner J; Dannecker G; Joester KE; Hettinger A; Niethammer D
    J Interferon Res; 1981; 1(3):373-80. PubMed ID: 6180069
    [No Abstract]   [Full Text] [Related]  

  • 58. [The drug of first choice: interferon. Clinical pharmacological principles].
    Del Vecchio S; Dianzani F
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):81-7. PubMed ID: 7542487
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of interferon on leukemia].
    Kimura I; Takahashi I
    Nihon Rinsho; 1981 Aug; 39(8):2837-43. PubMed ID: 6174754
    [No Abstract]   [Full Text] [Related]  

  • 60. How does interferon inhibit tumor growth?
    Gresser I
    Interferon; 1985; 6():93-126. PubMed ID: 2410371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.